CA2908620A1 - Derives antimicrobiens d'azithromycine a effet pharmaceutique non antibiotique - Google Patents

Derives antimicrobiens d'azithromycine a effet pharmaceutique non antibiotique

Info

Publication number
CA2908620A1
CA2908620A1 CA2908620A CA2908620A CA2908620A1 CA 2908620 A1 CA2908620 A1 CA 2908620A1 CA 2908620 A CA2908620 A CA 2908620A CA 2908620 A CA2908620 A CA 2908620A CA 2908620 A1 CA2908620 A1 CA 2908620A1
Authority
CA
Canada
Prior art keywords
group
compound
formula
mmol
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2908620A
Other languages
English (en)
Inventor
Fridrik Gardarsson
Susanne GULDBERG
Magnus Gardarsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROBIOTIC PHARMACEUTICALS APS
Original Assignee
PROBIOTIC PHARMACEUTICALS APS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROBIOTIC PHARMACEUTICALS APS filed Critical PROBIOTIC PHARMACEUTICALS APS
Publication of CA2908620A1 publication Critical patent/CA2908620A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2908620A 2013-04-10 2014-04-10 Derives antimicrobiens d'azithromycine a effet pharmaceutique non antibiotique Abandoned CA2908620A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS050050 2013-04-10
IS50050 2013-04-10
PCT/DK2014/050092 WO2014166503A1 (fr) 2013-04-10 2014-04-10 Dérivés antimicrobiens d'azithromycine à effet pharmaceutique non antibiotique

Publications (1)

Publication Number Publication Date
CA2908620A1 true CA2908620A1 (fr) 2014-10-16

Family

ID=50513631

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2908620A Abandoned CA2908620A1 (fr) 2013-04-10 2014-04-10 Derives antimicrobiens d'azithromycine a effet pharmaceutique non antibiotique

Country Status (5)

Country Link
US (1) US20160031925A1 (fr)
EP (1) EP2984087A1 (fr)
AU (1) AU2014252462A1 (fr)
CA (1) CA2908620A1 (fr)
WO (1) WO2014166503A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201520419D0 (en) 2015-11-19 2016-01-06 Epi Endo Pharmaceuticals Ehf Compounds
WO2021138847A1 (fr) * 2020-01-08 2021-07-15 Beijing Continent Pharmaceuticals Co., Ltd. Composé macrolide et son utilisation pour le traitement d'une maladie respiratoire chronique
US20230137567A1 (en) 2020-03-12 2023-05-04 Zoetis Services Llc Immunomodulating trifluoromethyl-aminal azalides
CN118139870A (zh) 2021-09-07 2024-06-04 硕腾服务有限责任公司 免疫调节氮环内酯
GB202404587D0 (en) 2024-03-28 2024-05-15 Epiendo Pharmaceuticals Ehf Chemical forms

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283055B1 (fr) * 1987-09-03 1990-08-29 SOUR PLIVA farmaceutska, Kemijska prehrambena i kozmeticka industrija, n.sol.o. Dérivés de 10-dihydro-10-déoxo-11-azaérythronolide-A, procédés et intermédiaires pour leur préparation et leur utilisation dans et pour la préparation de médicaments
AU7961498A (en) 1997-06-26 1999-01-19 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment
AR023264A1 (es) * 1999-04-08 2002-09-04 Hokuriku Pharmaceutical Derivados de eritromicina
AU2003211113B2 (en) * 2002-02-15 2007-08-09 Merckle Gmbh Antibiotic conjugates
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US20060183696A1 (en) 2004-08-12 2006-08-17 Pliva-Istrazivacki Institut D.O.O. Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract
CA2585711A1 (fr) 2004-10-27 2006-05-04 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Conjugues a activite anti-inflammatoire
DE602006004555D1 (de) * 2005-01-13 2009-02-12 Glaxosmithkline Zagreb Decladinosyl-macrolide mit entzündungshemmender wirkung
RS51479B (en) 2005-01-13 2011-04-30 Glaxo Group Limited MACROLIDES WITH ANTI-INFLAMMATORY ACTION
WO2007093840A2 (fr) 2006-02-15 2007-08-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Utilisation de conjugués spécifiques de cellule pour traiter des maladies inflammatoires des voies gastro-intestinales
GB201105633D0 (en) 2011-04-01 2011-05-18 Norbrook Lab Ltd Antibotic compounds

Also Published As

Publication number Publication date
WO2014166503A1 (fr) 2014-10-16
AU2014252462A1 (en) 2015-10-01
US20160031925A1 (en) 2016-02-04
EP2984087A1 (fr) 2016-02-17

Similar Documents

Publication Publication Date Title
AU707779B2 (en) Substituted liposaccharides useful in the treatment and prevention of endotoxemia
RU2330856C2 (ru) Макролидные соединения, обладающие противовоспалительной активностью
KR20150006082A (ko) 거대고리 다형체, 이런 다형체를 포함하는 조성물, 및 이의 사용 및 제조방법
CA2908620A1 (fr) Derives antimicrobiens d'azithromycine a effet pharmaceutique non antibiotique
JPH05255342A (ja) ４ａ−置換アベルメクチン誘導体
JP2008519787A (ja) マクロロン化合物
JP6826130B2 (ja) バンコマイシン誘導体、その製造方法、医薬組成物及び用途
WO2017124222A1 (fr) Procédé et intermédiaire pour la préparation de la tulathromycine
HU206221B (en) Process for producing acylated derivatives of etoposide and pharmaceutical compositions comprising such compounds as active ingredient
JP4709774B2 (ja) 抗炎症活性を有するマクロライド
US9550802B2 (en) Anti-inflammatory macrolides
WO2011131749A1 (fr) Nouveaux macrolides à 14 et 15 chaînons pour le traitement de maladies inflammatoires à dominance en neutrophiles
JP5680535B2 (ja) 新規フラバノン誘導体
KR20020007415A (ko) 마크롤라이드계 항생제의 신규 결정형
EP2271656A1 (fr) Macrolides 2'-o,3'-n-pontés
KR20020063885A (ko) 하이그로마이신 유도체
JPS5931796A (ja) Ｄｍｔのｃ−２３−修飾誘導体
CN110655543A (zh) 一种泰拉霉素新晶型及其制备方法
TW201815394A (zh) 具有改良口服生物可利用性之純七硫酸化雙醣
BG107265A (bg) Производни на хигромицин а за лечение на инфекцииот бактерии и протозои
CZ280809B6 (cs) Deriváty 10,11,12,13-tetrahydrodesmykosinu, způsoby jejich přípravy a jejich použití v léčivech
JP2906663B2 (ja) ５−０−デソサミニルエリスロノライドａ誘導体
JP2023505389A (ja) マクロライド化合物及びその慢性呼吸器疾患の治療用途
JPH0782292A (ja) 新規なグリチルレチン酸関連化合物又はそれらの塩
JPH0278695A (ja) エリスロマイシン誘導体

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20190410